89 related articles for article (PubMed ID: 3530851)
1. A new case of abnormal insulinemia with diabetes. Reduced insulin values determined by radioreceptor assay.
Iwamoto Y; Sakura H; Ishii Y; Yamamoto R; Kumakura S; Sakamoto Y; Matsuda A; Kuzuya T
Diabetes; 1986 Nov; 35(11):1237-42. PubMed ID: 3530851
[TBL] [Abstract][Full Text] [Related]
2. Familial hyperinsulinemia associated with secretion of an abnormal insulin, and coexistence of insulin resistance in the propositus.
Vinik AI; Seino S; Funakoshi A; Schwartz J; Matsumoto M; Schteingart DE; Fu ZZ; Tsai ST
J Clin Endocrinol Metab; 1986 Apr; 62(4):645-52. PubMed ID: 3512591
[TBL] [Abstract][Full Text] [Related]
3. Reduced urinary insulin clearance in patient with abnormal insulinemia.
Yamamoto R; Iwamoto Y; Sakura H; Yoshioka N; Hsieh SD; Matsuda A; Kuzuya T
Diabetes; 1987 May; 36(5):602-6. PubMed ID: 3552792
[TBL] [Abstract][Full Text] [Related]
4. Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.
Sakura H; Iwamoto Y; Sakamoto Y; Kuzuya T; Hirata H
J Clin Invest; 1986 Dec; 78(6):1666-72. PubMed ID: 3537011
[TBL] [Abstract][Full Text] [Related]
5. Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.
Haneda M; Polonsky KS; Bergenstal RM; Jaspan JB; Shoelson SE; Blix PM; Chan SJ; Kwok SC; Wishner WB; Zeidler A
N Engl J Med; 1984 May; 310(20):1288-94. PubMed ID: 6371526
[TBL] [Abstract][Full Text] [Related]
6. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.
Nanjo K; Sanke T; Miyano M; Okai K; Sowa R; Kondo M; Nishimura S; Iwo K; Miyamura K; Given BD
J Clin Invest; 1986 Feb; 77(2):514-9. PubMed ID: 3511099
[TBL] [Abstract][Full Text] [Related]
7. Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.
Shoelson SE; Polonsky KS; Zeidler A; Rubenstein AH; Tager HS
J Clin Invest; 1984 May; 73(5):1351-8. PubMed ID: 6371057
[TBL] [Abstract][Full Text] [Related]
8. [Radioreceptor assay of insulin and detection of anti-insulin receptor antibody using human placenta and their clinical application].
Kadota S
Hokkaido Igaku Zasshi; 1984 Nov; 59(6):750-61. PubMed ID: 6397418
[TBL] [Abstract][Full Text] [Related]
9. Radioreceptor assay for insulin.
Suzuki K; Ohsawa N; Kosaka K
J Clin Endocrinol Metab; 1976 Feb; 42(2):399-402. PubMed ID: 177444
[TBL] [Abstract][Full Text] [Related]
10. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
[TBL] [Abstract][Full Text] [Related]
11. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
12. A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).
Yano H; Kitano N; Morimoto M; Polonsky KS; Imura H; Seino Y
J Clin Invest; 1992 Jun; 89(6):1902-7. PubMed ID: 1601997
[TBL] [Abstract][Full Text] [Related]
13. Familial type C syndrome of insulin resistance and short stature with possible autosomal dominant transmission.
Nakamura F; Taira M; Hashimoto N; Makino H; Sasaki N
Endocrinol Jpn; 1989 Jun; 36(3):349-58. PubMed ID: 2684618
[TBL] [Abstract][Full Text] [Related]
14. Abnormal insulinemia.
Nanjo K; Kondo M; Sanke T; Nishi M
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S135-41. PubMed ID: 7859595
[TBL] [Abstract][Full Text] [Related]
15. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.
Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M
Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142
[TBL] [Abstract][Full Text] [Related]
16. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin.
Gruppuso PA; Gorden P; Kahn CR; Cornblath M; Zeller WP; Schwartz R
N Engl J Med; 1984 Sep; 311(10):629-34. PubMed ID: 6382002
[TBL] [Abstract][Full Text] [Related]
17. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis.
O'Brien TD; Hayden DW; Johnson KH; Stevens JB
Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345
[TBL] [Abstract][Full Text] [Related]
18. [Insulinemia--a marker of early diagnosis and control of efficacy of treatment of type II diabetes].
Szybiński Z; Szurkowska M
Pol Arch Med Wewn; 2001 Sep; 106(3):793-800. PubMed ID: 11928588
[TBL] [Abstract][Full Text] [Related]
19. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
[TBL] [Abstract][Full Text] [Related]
20. A radioreceptor assay for serum insulin.
Ozaki S; Kalant N
J Lab Clin Med; 1977 Oct; 90(4):686-99. PubMed ID: 903698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
